451.33MMarket Cap-18.77P/E (TTM)
2.465High2.330Low5.65MVolume2.440Open2.440Pre Close13.67MTurnover3.20%Turnover RatioLossP/E (Static)184.97MShares8.21052wk High-2.55P/B431.81MFloat Cap2.20052wk Low--Dividend TTM176.97MShs Float32.840Historical High--Div YieldTTM5.53%Amplitude2.200Historical Low2.418Avg Price1Lot Size
Leslie's Stock Forum
Man, I have been watching these guys for a while, and tons of hedges and institutions piled in.
Except nobody can afford their stuff. More evidence of the disconnect between Old Money and reality. In their day, it may have been a good buy.
Not until pay keeps up with inflation. LOL
$SPDR S&P Retail ETF (XRT.US)$
$Progressive (PGR.US)$ $Nikola (NKLA.US)$ $Humana (HUM.US)$ $PainReform (PRFX.US)$ $Chijet Motor (CJET.US)$ $Biodexa Pharmaceuticals (BDRX.US)$ $Leslie's (LESL.US)$ $NVIDIA (NVDA.US)$ $Elevance Health (ELV.US)$ $SAI TECH Global (SAI.US)$
• $Funko (FNKO.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $Southwest Airlines (LUV.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $MetLife (MET.US)$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment (MTG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake (SNOW.US)$ : JPMorgan Upgrades to Overweigh...
• $DCP Midstream (DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's (LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $Logitech International (LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $NIO Inc (NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet (OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals (ORIC.US)$ : Citigro...
$Jounce Therapeutics (JNCE.US)$ buyin 7.20 sell 13.15.
$Leslie's (LESL.US)$
buy in 22.38 sell 26.00
$DXC Technology (DXC.US)$
buy in 34.40 sell 43.30
$Cemex (CX.US)$
buy in 7.62 sell 8.66
$Braskem (BAK.US)$
in breakout still.
No comment yet